2005, Number 1
<< Back Next >>
Cir Cir 2005; 73 (1)
Breast cancer associated with pregnancy
Gallegos-Hernández JF
Language: Spanish
References: 25
Page: 51-56
PDF size: 59.69 Kb.
ABSTRACT
Invasive breast carcinoma diagnosed during pregnancy and even one year after delivery is known as breast cancer associated with pregnancy. There are many controversies surrounding this entity concerning diagnosis and therapeutics as well as to the behavior regarding the fetus. There is broad information in the existing literature. We can find authors who do not change the diagnostic-therapeutic approach of the neoplasia and those who even advise pregnancy interruption and consider greater aggressiveness in treatment, in comparison to the same cancer in a non-pregnant woman. The prognosis of breast cancer associated with pregnancy has also been a controversial issue. Historically, it has been considered to have the worst evolution. Nevertheless, evidence recently has shown that the known prognosis factors in breast cancer (stage, nodular status, receptors, etc.) are those associated with the prognosis and not the pregnancy itself. The objective of this article is to analyze, based on the existing evidence in the literature, which is the best diagnostic-therapeutic route for breast cancer associated with pregnancy, which procedures must be followed with the mother and the fetus and which is the ideal therapeutic sequence, analyzing at the same time the possibilities of axillary preservation by means of lymphatic mapping and sentinel node biopsy in these patients.
REFERENCES
Scott-Conner CEH, Jochimsen PR, Sorosky JI. Breast cancer in pregnancy. In: Roses DF, editor. Breast cancer. New York: Churchill Livingstone;1999. p. 688.
Theriault RL. Breast cancer during pregnancy. In: Singletary ES, Robb GL, editors. Advanced herapy of breast disease. Hamilton, B.C.: Decker; 2000. p. 344.
Holleb AI, Farrow JH. The relation of carcinoma of the breast and pregnancy in 283 patients. Surg Gynecol Obstet 1962;115:65-71.
Chiechi LM, Lobascio A, Loizzi P. Breast cancer in pregnancy. Resistance to screeni. Minerva Ginecol 1998;50:301-304.
Fuentes-Alburo A, Chávez-McGregor R, Ramirez-Ugalde MT, et al. Early detection of breast cancer: who is responsible? Br Cancer Res Treat 2000;64(abstract 205). 23rd Annual San Antonio Breast Cancer Symposium.
Kline TS, Lash S. The bleeding nipple of pregnancy and postpartum. A cytologic and histologic study. Acta Cytol 1984;8:336-340.
Dooley WC, Veronesi U, Elledge R, et al. Detection of pre-malignant and malignant breast cells by ductal lavage. Br Cancer Res Treat 2000;64(abstract 17). 23rd Annual San Antonio Breast Cancer Symposium.
Samuel TH, Siu FF, Yaffe M, et al. Gestational breast cancer. Can Assoc Radiol J 1988;49:172-180.
Ishida T, Yokoe T, Kasumi F, et al. Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case–control study in Japan. Jpn J Cancer Res 1992;83:1143-1149.
Daling JR, Malone KE. Voigt LF, et al. Risk of breast cancer among young women: relationship to induced abortion. J Natl Cancer Inst 1994;86:1584-1592.
Marchant DJ. Breast cancer in pregnancy. Clin Obstet Gynecol 1994;37:993-997.
Bass JE, Huynh PT. Imaging of the breast: pregnancy and lactation. In: Singletary ES, Robb GL, editors. Advanced therapy of breast disease. Hamilton, B.C.: Decker; 2000. p. 344.
Stavros AT, Thickman D, Rapp CL, et al. Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology 1995;196:123-134.
Lister D, Evans AJ, Burrell HC, et al. The accuracy of breast ultrasound in the evaluation of clinically benign discrete, symptomatic breast lumps. Clin Radiol 1998;53:490-492.
Cheek JH. Survey of current opinions concerning carcinoma of the breast during pregnancy. Arch Surg 1953;66:664-672.
Morton DL, Wen DR, Wong J, et al. Technical details of intraopera- tive lymphatic mapping for early stage melanoma. Arch Surg 1992; 127:392-399.
Gallegos-Hernández JF, Gutiérrez-Carrillo F, Barroso-Bravo S, y cols. Identificación del ganglio centinela con azul patente V en pacientes con melanoma cutáneo. Gac Med Mex 1998;134:285-288.
Giuliano AE, Jones RC, Brennan M, et al. Sentinel lymphadenectomy in breast cancer J Clin Oncol 1997;15:2345-2350.
Gallegos-Hernández JF. Cirugía etapificadora con mínima invasión axilar en cáncer de mama. El valor del ganglio centinela. Ginecol Obstet Mex 2002;70:7-10.
Nicklas AH, Baker ME. Imaging strategies in the pregnant cancer patients. Semin Oncol 2000;27:623-632.
Nugent N, Hill AD, Casey M, et al. Safety guidelines for radiolocalised sentinel node resection. Ir Med Sci 2001;170:236-238.
Gallegos-Hernández JF, Chávez-García MA. Utilidad del mapeo linfático con inyección subareolar de colorante azul patente en la etapificación del cáncer de mama. Rev Invest Clin 2003;55:407-411.
Blatt J, Mulvihill JJ, Ziegler JL, et al. Pregnancy outcome following cancer chemotherapy. Am J Med 1980;69:828-832.
Hudis CA, Norton L. Adjuvant therapy for breast cancer. In: Singletary ES, Robb GL, editors. Advanced therapy of breast disease. Hamilton, BC: Decker; 2000.pp.257-263.
Berry DL, Theriault RL, Holmes FA, Parisi UM, Booser DJ, Singletary SE, Buzdar AU, Hortobagyi GN. Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol 1999;17:855-861.